As the U.S. stock market experiences a modest recovery with major indices inching higher, investors are keenly observing the impacts of potential tariff adjustments and economic data releases on ...

We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against ...

SPRINGFIELD, Mo. (KY3) - On Thursday, the U.S. Postal Service dedicated its new freshwater fishing lure stamps at Wonders of Wildlife in Springfield. This release celebrates the beauty and ...

SOUTH SAN FRANCISCO - CERo Therapeutics Holdings, Inc. (NASDAQ ... The findings were presented at the 2025 SITC Spring Scientific Cellular Therapy for Solid Tumors in San Diego, which took place from ...

CERo is presenting its research on CER-1236 from March 12-14, 2025, during the SITC Spring Scientific Cellular ... March 13, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq ...

SOUTH SAN FRANCISCO - CERo Therapeutics Holdings ... The findings were presented at the 2025 SITC Spring Scientific Cellular Therapy for Solid Tumors in San Diego, which took place from March ...

Building a climate-controlled warehouse and logistics facility for United Therapeutics in North Carolina’s Research Triangle was a matter of power management and careful planning. The facility ...

SpringWorks Therapeutics stock opened at $50.88 on Thursday. The company’s 50 day simple moving average is $45.24 and its 200-day simple moving average is $39.04. The company has a market ...

SpringWorks Therapeutics portfolio features Ogsiveo for desmoid tumors and Gomekli for NF1‑plexiform neurofibromas. In fact, Ogsiveo’s revenues alone reached $172 million in 2024, supported by ...

MONTGOMERY COUNTY, Md. (7News) — A 23-year-old man is dead after Montgomery County police said he was found shot in a Silver Spring parking lot on Saturday. Officers with the Montgomery County ...

After years of research into xenotransplantation, the field is at a turning point—yet risks and ethical issues remain ...